Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1955 Jan;34(1):9–19. doi: 10.1172/JCI103067

THE EFFECT OF GLASS UPON THE ACTIVITY OF THE VARIOUS PLASMA CLOTTING FACTORS

Samuel I Rapaport 1,1,2, Knut Aas 1, Paul A Owren 1
PMCID: PMC438573  PMID: 13221649

Full text

PDF
9

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AGGELER P. M., WHITE S. G., GLENDENING M. B., PAGE E. W., LEAKE T. B., BATES G. Plasma thromboplastin component (PTC) deficiency; a new disease resembling hemophilia. Proc Soc Exp Biol Med. 1952 Apr;79(4):692–694. doi: 10.3181/00379727-79-19488. [DOI] [PubMed] [Google Scholar]
  2. AGGELER P. M., WHITE S. G., SPAET T. H. Deuterohemophilia: plasma thromboplastin factor B deficiency: plasma thromboplastin component (PTC) deficiency, Christmas disease, hemophilia B. Blood. 1954 Mar;9(3):246–253. [PubMed] [Google Scholar]
  3. ALEXANDER B., LANDWEHR G. Evolution of a prothrombin conversion accelerator in stored human plasma and prothrombin fractions. Am J Physiol. 1949 Nov;159(2):322–331. doi: 10.1152/ajplegacy.1949.159.2.322. [DOI] [PubMed] [Google Scholar]
  4. BIGGS R., DOUGLAS A. S., MACFARLANE R. G. The initial stages of blood coagulation. J Physiol. 1953 Dec 29;122(3):538–553. doi: 10.1113/jphysiol.1953.sp005019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Conley C. L., Hartmann R. C., Morse W. I., 2nd THE CLOTTING BEHAVIOR OF HUMAN "PLATELET-FREE" PLASMA: EVIDENCE FOR THE EXISTENCE OF A "PLASMA THROMBOPLASTIN". J Clin Invest. 1949 Mar;28(2):340–352. doi: 10.1172/JCI102077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. FIALA S. A thermolabile inhibitor of plasma coagulation. Nature. 1951 Feb 17;167(4242):279–279. doi: 10.1038/167279a0. [DOI] [PubMed] [Google Scholar]
  7. FIALA S. On the role of a protein inhibitor in the first stage of blood coagulation. Arch Int Physiol. 1951 Feb;58(4):386–411. doi: 10.3109/13813455109144971. [DOI] [PubMed] [Google Scholar]
  8. FIALA S., ROTH K. [Platelets and the thromboplastic system of blood coagulation]. Arch Int Physiol. 1953 Apr;61(2):205–231. doi: 10.3109/13813455309147710. [DOI] [PubMed] [Google Scholar]
  9. LANGDELL R. D., WAGNER R. H., BRINKHOUS K. M. Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure. J Lab Clin Med. 1953 Apr;41(4):637–647. [PubMed] [Google Scholar]
  10. LEWIS M. L., WARE A. G. The mechanism of action of human accelerator globulin and its relation to other clotting factors. Blood. 1954 May;9(5):520–530. [PubMed] [Google Scholar]
  11. Lozner E. L., Taylor F. H., Macdonald H. THE EFFECT OF FOREIGN SURFACES ON BLOOD COAGULATION. J Clin Invest. 1942 Mar;21(2):241–245. doi: 10.1172/JCI101295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. MILSTONE J. H. The problem of the lipoid thromboplastins. Yale J Biol Med. 1950 Jul;22(6):675–687. [PMC free article] [PubMed] [Google Scholar]
  13. OWREN P. A., AAS K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand J Clin Lab Invest. 1951;3(3):201–208. doi: 10.3109/00365515109060600. [DOI] [PubMed] [Google Scholar]
  14. OWREN P. A. Prothrombin and accessory factors; clinical significance. Am J Med. 1953 Feb;14(2):201–215. doi: 10.1016/0002-9343(53)90019-9. [DOI] [PubMed] [Google Scholar]
  15. QUICK A. J., EPSTEIN E. Thromboplastic activity in human blood. J Appl Physiol. 1952 May;4(11):840–847. doi: 10.1152/jappl.1952.4.11.840. [DOI] [PubMed] [Google Scholar]
  16. QUICK A. J. The pathological physiology of hemorrhagic conditions. Bull N Y Acad Med. 1953 Mar;29(3):226–234. [PMC free article] [PubMed] [Google Scholar]
  17. RAPAPORT S. I., AAS K., OWREN P. A. The coagulant activity of Russel viper venom. Scand J Clin Lab Invest. 1954;6(1):81–81. [PubMed] [Google Scholar]
  18. RAPAPORT S. I., AAS K., OWREN P. A. The increased coagulability of plasma exposed to glass. Scand J Clin Lab Invest. 1954;6(1):82–83. [PubMed] [Google Scholar]
  19. RAPAPORT S. I., AAS K., OWREN P. A. The lipid inhibitor of brain; mechanism of its anticoagulant action and its comparison with the soybean inositol phosphatide inhibitor. J Lab Clin Med. 1954 Sep;44(3):364–373. [PubMed] [Google Scholar]
  20. RATNOFF O. D., CONLEY C. L. The role of surface and of calcium in the coagulation of a globulin fraction of platelet-deficient plasma. Bull Johns Hopkins Hosp. 1951 Sep;89(3):245–254. [PubMed] [Google Scholar]
  21. TOCANTINS L. M., HOLBURN R. R., CARROLL R. T. Response of plasma to excess of thromboplastin as a measure of prothrombin activity. Proc Soc Exp Biol Med. 1951 Apr;76(4):623–630. doi: 10.3181/00379727-76-18579. [DOI] [PubMed] [Google Scholar]
  22. TOCANTINS L. M. Hemophilic syndromes and hemophilia. Blood. 1954 Mar;9(3):281–285. [PubMed] [Google Scholar]
  23. WARE A. G., STRAGNELL R. An improved one-stage prothrombin method. Am J Clin Pathol. 1952 Aug;22(8):791–797. doi: 10.1093/ajcp/22.8_ts.791. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES